Screener
Amphastar Pharmaceuticals AMPH Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 47.7%-2.2pp | 47.3%-3.2pp | 49.5%-1.6pp | 49.4%-3.6pp | 49.9%-4.8pp | |
| Operating margin | 15.7%-9.5pp | 16.2%-10.4pp | 19.5%-8.6pp | 20.7%-8.9pp | 25.1%-7.1pp | |
| Net margin | 10.8%-7.9pp | 11%-8.4pp | 13.6%-8.2pp | 15.4%-6.4pp | 18.6%-4.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.5×0.0× | 0.5×0.0× | |
| Liquidity | ||||||
| Current ratio | 2.4×-0.9× | 3.9×+0.9× | 4×+0.9× | 3.1×-0.3× | 3.3×-0.2× | |
| Leverage | ||||||
| Net debt / EBITDA | 2.7×+0.7× | 2.7×+0.8× | 2.5×+0.5× | 2.1×+0.5× | 2×+0.4× | |
| Valuation | ||||||
| Market capitalization | $873.48M-28.0% | $888.8M-35.7% | $1.23B-31.1% | $1.24B-47.9% | $1.16B-40.8% | |
| Price / earnings | 11.1×+2.1× | 11.2×+1.5× | 12.5×+1.4× | 11.1×-4.0× | 8.6×-3.1× | |
| Price / sales | 1.2×-0.5× | 1.2×-0.7× | 1.7×-0.7× | 1.7×-1.6× | 1.6×-1.1× | |
| EV / EBITDA | 8.1×+0.7× | 7.8×+0.3× | 8.7×-0.1× | 8.2×-2.4× | 6.9×-1.6× |
FAQ
- What are Amphastar Pharmaceuticals's profit margins?
- Amphastar Pharmaceuticals (AMPH) runs a 47.7% gross margin and a 15.7% operating margin, with a 10.8% net margin.
- Where do Amphastar Pharmaceuticals's ratios come from?
- Every ratio is computed from Amphastar Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
